Systematic Review on Upper Urinary Tract Carcinoma in Kidney Transplant Recipients
Authors:
- Alberto PianaAPAlberto Piana
- Alicia López-AbadALAlicia López-Abad
- Battista LanzillottaBLBattista Lanzillotta
- Alessio PecoraroAPAlessio Pecoraro
- Thomas PrudhommeTPThomas Prudhomme
- Hakan Bahadır HaberalHHHakan Bahadır Haberal
- Michele Di DioMichele Di Dio
- Beatriz Bañuelos MarcoBMBeatriz Bañuelos Marco
- Muhammet Irfan DönmezMDMuhammet Irfan Dönmez
- Alberto BredaABAlberto Breda
- Angelo TerritoATAngelo Territo
Open Access
- 3 June 2025
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (11) , 3927
Abstract
Objectives: Upper urinary tract urothelial cell carcinoma (UTUC) in kidney transplant recipients (KTRs) presents distinct clinical challenges due to the complexities of managing both cancer and the long-term immunosuppressive therapy required to preserve graft function. UTUC in this population often presents at advanced stages, contributing to poorer outcomes compared to immunocompetent individuals. Methods: This systematic review (SR) evaluates the incidence, clinical presentation, treatment approaches, and survival outcomes of UTUC in KTRs, based on 16 retrospective studies including 526 patients. Results: The present study highlights a predominance of female patients (ranging from 50% to 91.6%) and significant variability in time to diagnosis (from 7 to 181 months post-transplant). Tumor characteristics also showed considerable heterogeneity, with high-grade and advanced-stage (T3–T4) tumors being more common. The standard treatment for UTUC in KTRs remains radical nephroureterectomy (RNU), with additional resection of the bladder (TURB) when bladder cancer (BC) coexists. Survival outcomes vary significantly, with 5-year overall survival (OS) rates ranging from 16.7% to 90.9%, strongly influenced by tumor stage at diagnosis. This SR further reports high rates of bladder recurrence (18.8% to 61.2%) and challenges in balancing effective cancer treatment with graft preservation. The variability in immunosuppressive regimens across studies complicates the assessment of their role in UTUC progression. The limitations of the current evidence include small sample sizes, retrospective designs, and inconsistent follow-up durations. Conclusions: This SR underscores the need for tailored treatment strategies and improved long-term surveillance. Future research should focus on prospective studies with larger cohorts, exploring the impact of immunosuppression and novel therapies on UTUC outcomes in KTRs.Keywords
This publication has 32 references indexed in Scilit:
- Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working GroupEuropean Urology Focus, 2025
- Benefit and Harms of Radical Nephroureterectomy as Part of a Multimodal Treatment Strategy for Upper Tract Urothelial Carcinoma Patients Presenting with Clinical Evidence of Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis by the European Association of Urology GuidelinesEuropean Urology Oncology, 2025
- Differential effect of surgical technique on intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial cancer: a systematic review and Meta-analysisWorld Journal of Urology, 2024
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 UpdateEuropean Urology, 2023
- European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)European Urology, 2022
- Upper urinary tract urothelial carcinoma behaviors in patients with end-stage renal disease after kidney transplantation in TaiwanInternational Urology and Nephrology, 2016
- Distinguishing Characteristics of Urothelial Carcinoma in Kidney Transplant Recipients Between China and Western CountriesTransplantation Proceedings, 2013
- Transperitoneal laparoscopic nephroureterectomy for native upper tract urothelial carcinoma in renal transplant recipientsWorld Journal of Urology, 2012
- Urothelial Cancer After Renal Transplantation: An UpdateTransplantation Proceedings, 2012
- Denovo urothelial carcinoma of the upper and lower urinary tract in kidney ? transplant patients with end-stage analgesic nephropathyWorld Journal of Urology, 1995